{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:49:23Z","timestamp":1787856563708,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T00:00:00Z","timestamp":1284508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s11908-010-0132-1","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T04:22:13Z","timestamp":1284438133000},"page":"409-416","source":"Crossref","is-referenced-by-count":30,"title":["Invasive Pulmonary Aspergillosis in Patients with Chronic Obstructive Pulmonary Disease: An Emerging Fungal Disease"],"prefix":"10.1007","volume":"12","author":[{"given":"Florence","family":"Ader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,15]]},"reference":[{"key":"132_CR1","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1086\/323900","volume":"33","author":"JR Perfect","year":"2001","unstructured":"Perfect JR, Cox GM, Lee JY, et al.: The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001, 33:1824\u20131833.","journal-title":"Clin Infect Dis"},{"key":"132_CR2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, et al.: Treatment of Aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008, 46:327\u2013360.","journal-title":"Clin Infect Dis"},{"key":"132_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/COPD.S4229","volume":"4","author":"F Ader","year":"2009","unstructured":"Ader F, Bienvenu AL, Rammaert B, Nseir S: Management of invasive aspergillosis in patients with COPD: rational use of voriconazole. Int J COPD 2009, 4:279\u2013287.","journal-title":"Int J COPD"},{"key":"132_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","volume":"45","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007, 45:205\u2013216.","journal-title":"Clin Infect Dis"},{"key":"132_CR5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","volume":"176","author":"KF Rabe","year":"2007","unstructured":"Rabe KF, Hurd S, Anzuet A, et al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532\u2013555.","journal-title":"Am J Respir Crit Care Med"},{"key":"132_CR6","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1183\/09031936.00018908","volume":"31","author":"KF Chung","year":"2008","unstructured":"Chung KF, Adcock IM: Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008, 31:1334\u20131356.","journal-title":"Eur Respir J"},{"key":"132_CR7","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","volume":"359","author":"S Sethi","year":"2008","unstructured":"Sethi S, Murphy TF: Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008, 359:2355\u20132365.","journal-title":"N Engl J Med"},{"key":"132_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","volume":"79","author":"TF Patterson","year":"2000","unstructured":"Patterson TF, Kirkpatrick WR, White M, et al.: Invasive aspergillosis: disease spectrum, treatment practices and outcomes. Medicine 2000, 79:250\u2013260.","journal-title":"Medicine"},{"key":"132_CR9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","volume":"32","author":"SJ Lin","year":"2001","unstructured":"Lin SJ, Schranz J, Teutsch SM: Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001, 32:358\u2013366.","journal-title":"Clin Infect Dis"},{"key":"132_CR10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00007611-199107000-00004","volume":"84","author":"G Thommi","year":"1991","unstructured":"Thommi G, Bell G, Liu J, Nugent K: Spectrum of invasive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary disease. South Med J 1991, 84:828\u2013831.","journal-title":"South Med J"},{"key":"132_CR11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1086\/517672","volume":"26","author":"J Rello","year":"1998","unstructured":"Rello J, Esandi ME, Mariscal D, et al.: Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998, 26:1473\u20131475.","journal-title":"Clin Infect Dis"},{"key":"132_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1469-0691.2005.01143.x","volume":"11","author":"F Ader","year":"2005","unstructured":"Ader F, Nseir S, Le Berre R, et al.: Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005, 11:427\u2013429.","journal-title":"Clin Microbiol Infect"},{"key":"132_CR13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"\u2022\u2022 Bulpa P, Dive A, and Sibille Y: Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007, 30:782\u2013800. This study was the first to propose specific definitions of IPA in COPD patients. The \u201cBulpa criteria\u201d are currently used to estimate the probability of IPA in COPD patients.","journal-title":"Eur Respir J"},{"key":"132_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1479972307085637","volume":"5","author":"P Samarakoon","year":"2008","unstructured":"Samarakoon P, Soubani AO: Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 2008, 5:19\u201327.","journal-title":"Chron Respir Dis"},{"key":"132_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0256-4947.62828","volume":"30","author":"X Gao","year":"2010","unstructured":"Gao X, Chen L, Hu G, Mei H: Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests. Ann Saudi Med 2010, 30: 193\u2013197.","journal-title":"Ann Saudi Med"},{"key":"132_CR16","unstructured":"\u2022\u2022 Guinea J, Torres-Narbona M, Gijon P, et al.: Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2009 (Epub ahead of print). This study presents and analyzes the largest retrospective series of COPD patients with positive Aspergillus specimens in LRT at admission who subsequently develop IPA."},{"key":"132_CR17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","volume":"170","author":"W Meersseman","year":"2004","unstructured":"Meersseman W, Vandecasteele SJ, Wilmer A, et al.: Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004, 170:621\u2013625.","journal-title":"Am J Respir Crit Care Med"},{"key":"132_CR18","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc3488","volume":"9","author":"J Garnacho-Monteiro","year":"2005","unstructured":"Garnacho-Monteiro J, Amaya-Villar R, Ortiz-Leyba C, et al.: Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005, 9:R191\u2013R199.","journal-title":"Crit Care"},{"key":"132_CR19","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s00134-007-0791-z","volume":"33","author":"RJ Trof","year":"2007","unstructured":"Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, et al.: Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Int Care Med 2007, 33:1694\u20131703.","journal-title":"Int Care Med"},{"key":"132_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J, et al.: Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008, 177:27\u201334.","journal-title":"Am J Respir Crit Care Med"},{"key":"132_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1179\/joc.2003.15.1.71","volume":"15","author":"G Dimopoulos","year":"2003","unstructured":"Dimopoulos G, Piagnerelli M, Berre J, et al.: Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003, 15:71\u201375.","journal-title":"J Chemother"},{"key":"132_CR22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcrc.2006.03.006","volume":"21","author":"F Khasawneh","year":"2006","unstructured":"Khasawneh F, Mohamad T, Moughrabieh MK, et al.: Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care 2006, 21:322\u2013327.","journal-title":"J Crit Care"},{"key":"132_CR23","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al.: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813\u20131821.","journal-title":"Clin Infect Dis"},{"key":"132_CR24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","volume":"44","author":"A Upton","year":"2007","unstructured":"Upton A, Kirby KA, Carpenter P, et al.: Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007, 44: 531\u2013540.","journal-title":"Clin Infect Dis"},{"key":"132_CR25","first-page":"1","volume":"4","author":"L Romani","year":"2004","unstructured":"Romani L: Immunity to fungal infections. Nat Immunol 2004, 4:1\u201313.","journal-title":"Nat Immunol"},{"key":"132_CR26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.04.00064004","volume":"24","author":"T Betsuyaku","year":"2004","unstructured":"Betsuyaku T, Kuroki I, Nagai K, et al.: Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 2004, 24:964\u2013970.","journal-title":"Eur Respir J"},{"key":"132_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1164\/rccm.200509-1461OC","volume":"174","author":"CS Berenson","year":"2006","unstructured":"Berenson CS, Wrona CT, Grove LJ: Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. Am J Respir Crit Care Med 2006, 174:31\u201340.","journal-title":"Am J Respir Crit Care Med"},{"key":"132_CR28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1378\/chest.08-0422","volume":"134","author":"AS Cowburn","year":"2008","unstructured":"Cowburn AS, Condliffe AM, Farahi N, et al.: Advances in neutrophil biology: clinical implications. Chest 2008, 134: 606\u2013612.","journal-title":"Chest"},{"key":"132_CR29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1465-9921-6-68","volume":"6","author":"D Droemann","year":"2005","unstructured":"Droemann D, Goldmann T, Tiedje T, et al.: Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005, 6:68.","journal-title":"Respir Res"},{"key":"132_CR30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1465-9921-8-84","volume":"8","author":"RE MacRedmond","year":"2007","unstructured":"MacRedmond RE, Greene CM, Dorscheid DR, et al.: Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 2007, 8:84.","journal-title":"Respir Res"},{"key":"132_CR31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.clim.2007.05.004","volume":"124","author":"M Chignard","year":"2007","unstructured":"Chignard M, Balloy V, Sallenave JM, Si-Tahar M: Role of toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromised hosts. Clin Immunol 2007, 124:238\u2013243.","journal-title":"Clin Immunol"},{"key":"132_CR32","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1172\/JCI112166","volume":"76","author":"A Schaffner","year":"1985","unstructured":"Schaffner A: Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest 1985, 76:1755\u20131764.","journal-title":"J Clin Invest"},{"key":"132_CR33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/infdis\/147.1.160","volume":"147","author":"RD Diamond","year":"1983","unstructured":"Diamond RD: Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones. J Infect Dis 1983, 147:160\u2013162.","journal-title":"J Infect Dis"},{"key":"132_CR34","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1099\/13500872-140-9-2475","volume":"140","author":"TTC Ng","year":"1994","unstructured":"Ng TTC, Robson GD, Denning DW: Hydrocortisone enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994, 140:2475\u20132479.","journal-title":"Microbiology"},{"key":"132_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1086\/341971","volume":"36","author":"E Peter","year":"2002","unstructured":"Peter E, Bakri F, Ball DM, et al.: Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy. Clin Infect Dis 2002, 36:54\u201356.","journal-title":"Clin Infect Dis"},{"key":"132_CR36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0953-6205(03)90006-9","volume":"14","author":"R Barouky","year":"2003","unstructured":"Barouky R, Badet M, Saint Denis M, et al.: Inhaled corticosteroids in COPD and disseminated aspergillosis. Eur J Int Med 2003, 14:380\u2013382.","journal-title":"Eur J Int Med"},{"key":"132_CR37","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1469-0691.2003.00792.x","volume":"9","author":"M Cornet","year":"2003","unstructured":"Cornet M, Hallat H, Somme D, et al.: Fulminant invasive pulmonary aspergillosis in immunocompetent patients. A two-case report. Clin Microbiol Infect 2003, 9: 1224\u20131227.","journal-title":"Clin Microbiol Infect"},{"key":"132_CR38","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/593186","volume":"47","author":"L Martinez-Solano","year":"2008","unstructured":"Martinez-Solano L, Macia MD, Fajardo A, et al.: Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 2008, 47:1526\u20131533.","journal-title":"Clin Infect Dis"},{"key":"132_CR39","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/AAC.00234-08","volume":"52","author":"MJ Seidler","year":"2008","unstructured":"\u2022 Seidler MJ, Salvenmoser S, M\u00fcller FMC: Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob Agents Chemother 2008, 52:4130\u20134136. This is the first report of biofilm production by A. fumigatus on bronchial epithelial cells.","journal-title":"Antimicrob Agents Chemother"},{"key":"132_CR40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.200305-648OC","volume":"170","author":"IS Patel","year":"2004","unstructured":"Patel IS, Vlahos I, Wilkinson TM: Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:400\u2013407.","journal-title":"Am J Respir Crit Care Med"},{"key":"132_CR41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13693780802609604","volume":"47","author":"M Pihet","year":"2009","unstructured":"Pihet M, Carr\u00e8re J, Cimon B, et al.: Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis, a review. J Med Mycol 2009, 47:387\u2013397.","journal-title":"J Med Mycol"},{"key":"132_CR42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bmt.1702232","volume":"25","author":"E Jantunen","year":"2000","unstructured":"Jantunen E, Piilonen A, Volin L, et al.: Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000, 25:867\u2013871.","journal-title":"Bone Marrow Transplant"},{"key":"132_CR43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1399-3003.2000.15b30.x","volume":"15","author":"S Andreas","year":"2000","unstructured":"Andreas S, Heindl S, Wattky C, et al.: Diagnosis of pulmonary aspergillosis using optical brighteners. Eur Respir J 2000, 15:407\u2013411.","journal-title":"Eur Respir J"},{"key":"132_CR44","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood.V97.6.1604","volume":"97","author":"J Maertens","year":"2001","unstructured":"Maertens J, Verhaegen J, Lagrou K, et al.: Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001, 97:1604\u20131610.","journal-title":"Blood"},{"key":"132_CR45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","volume":"42","author":"CD Pfeiffer","year":"2006","unstructured":"Pfeiffer CD, Fine JP, Safdar N: Diagnosis of invasive aspergillosis using a galactomannan assay: a meta\u2013analysis. Clin Infect Dis 2006, 42:1417\u20131427.","journal-title":"Clin Infect Dis"},{"key":"132_CR46","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJM200312113492424","volume":"349","author":"A Sulahian","year":"2003","unstructured":"Sulahian A, Touratier S, Ribaud P: False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003, 349:2366\u20132367.","journal-title":"N Engl J Med"},{"key":"132_CR47","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1086\/382224","volume":"38","author":"C Viscoli","year":"2004","unstructured":"Viscoli C, Machetti M, Cappellano P, et al.: False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin\u2013tazobactam. Clin Infect Dis 2004, 38:913\u2013916.","journal-title":"Clin Infect Dis"},{"key":"132_CR48","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1128\/JCM.41.8.3922-3925.2003","volume":"41","author":"M Sanguinetti","year":"2003","unstructured":"Sanguinetti M, Posteraro B, Pagano L, et al.: Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2003, 41:3922\u20133925.","journal-title":"J Clin Microbiol"},{"key":"132_CR49","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1128\/JCM.42.12.5517-5522.2004","volume":"42","author":"B Musher","year":"2004","unstructured":"Musher B, Fredricks D, Leisenring W, et al.: Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004, 42:5517\u20135522.","journal-title":"J Clin Microbiol"},{"key":"132_CR50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.0933-7407.2001.93.x","volume":"44","author":"HJ Seyfarth","year":"2001","unstructured":"Seyfarth HJ, Nenoff P, Winkler J, et al.: Aspergillus detection in bronchoscopically acquired material. Significance and interpretation. Mycoses 2001, 44:356\u2013360.","journal-title":"Mycoses"},{"key":"132_CR51","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JCM.00077-07","volume":"45","author":"CJ Clancy","year":"2007","unstructured":"Clancy CJ, Jaber RA, Leather HL, et al.: Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007, 45:1759\u20131765.","journal-title":"J Clin Microbiol"},{"key":"132_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"\u2022 Meersseman W, Lagrou K, Maertens J, et al.: Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008, 177:27\u201334. This clinical study investigated GM detection in BAL fluid of ICU patients and underscored the usefulness of GM detection in establishing or excluding the diagnosis of IPA in the ICU.","journal-title":"Am J Respir Crit Care Med"},{"key":"132_CR53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1439-0507.1997.tb00249.x","volume":"40","author":"R Ansorg","year":"1997","unstructured":"Ansorg R, Van den Boom R, Rath PM: Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997, 40:353\u2013357.","journal-title":"Mycoses"},{"key":"132_CR54","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jac\/dkg367","volume":"52","author":"MJ Becker","year":"2003","unstructured":"Becker MJ, De Marie S, Fens MH, et al.: Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis. J Antimicrob Chemother 2003, 52:428\u2013434.","journal-title":"J Antimicrob Chemother"},{"key":"132_CR55","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","volume":"40","author":"KA Marr","year":"2005","unstructured":"Marr KA, Laverdiere M, Gugel A, Leisenring W: Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005, 40:1762\u20131769.","journal-title":"Clin Infect Dis"},{"key":"132_CR56","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","volume":"41","author":"L Ostrosky-Zeichner","year":"2005","unstructured":"Ostrosky-Zeichner L, Alexander BD, Kett DH, et al.: Multicenter clinical evaluation of the [1\u2013> 3]-\u03b2-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005, 41:654\u2013659.","journal-title":"Clin Infect Dis"},{"key":"132_CR57","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/jmm.0.05298-0","volume":"52","author":"S Okada","year":"2003","unstructured":"Okada S, Teramoto S, Takizawa H, et al.: Clinical insignificance of [1\u2013> 3]-\u03b2-D-glucan in early diagnosis of invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. J Med Microb 2003, 52:1031\u20131032.","journal-title":"J Med Microb"},{"issue":"Suppl 3","key":"132_CR58","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","volume":"37","author":"DW Denning","year":"2003","unstructured":"Denning DW, Riniotis K, Dobrashian R, Sambatakou H: Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003, 37(Suppl 3):S265\u2013S280.","journal-title":"Clin Infect Dis"},{"key":"132_CR59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jhin.2004.01.006","volume":"56","author":"KH Vandewoude","year":"2004","unstructured":"Vandewoude KH, Blot SI, Benoit D, et al.: Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect 2004, 56:269\u2013276.","journal-title":"J Hosp Infect"},{"key":"132_CR60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","volume":"44","author":"RE Greene","year":"2007","unstructured":"Greene RE, Schlamm HT, Oestmann JW, et al.: Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007, 44:373\u2013379.","journal-title":"Clin Infect Dis"},{"key":"132_CR61","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1469-0691.2009.02913.x","volume":"15","author":"WW Hope","year":"2009","unstructured":"Hope WW, Drusano GL: Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside. Clin Microbiol Infect 2009, 15:602\u2013612.","journal-title":"Clin Microbiol Infect"},{"key":"132_CR62","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, et al.: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002, 347:408\u2013415.","journal-title":"N Engl J Med"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-010-0132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-010-0132-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-010-0132-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:22:14Z","timestamp":1559420534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-010-0132-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,15]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1007\/s11908-010-0132-1","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,15]]}}}